Arno starts enrolling patients in Phase I/II trial of onapristone to treat prostate cancer
According to previous Phase II clinical trials, onapristone is shown to exhibit anti-tumour activity in patients with breast cancer. The pre-clinical testing has demonstrated that onapristone had blocked